zalcitabine has been researched along with Infection, Mycobacterium avium-intracellulare in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Klein, HG; Kumar, P; Merritt, S; Sacher, R; Sloand, E | 1 |
2 other study(ies) available for zalcitabine and Infection, Mycobacterium avium-intracellulare
Article | Year |
---|---|
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Transfusion of blood components to persons infected with human immunodeficiency virus type 1: relationship to opportunistic infection.
Topics: AIDS-Related Opportunistic Infections; Blood Component Transfusion; Blood Group Antigens; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Cell Count; Cytomegalovirus Infections; Didanosine; Erythrocyte Transfusion; Female; HIV-1; Humans; Isoantibodies; Male; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Risk Factors; Zalcitabine; Zidovudine | 1994 |